Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Total 13F shares
-
19,247,212
-
Share change
-
+3,269,873
-
Total reported value
-
$34,645,211
-
Put/Call ratio
-
87%
-
Price per share
-
$1.80
-
Number of holders
-
64
-
Value change
-
+$6,651,468
-
Number of buys
-
35
-
Number of sells
-
13
Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q1 2024
As of 31 Mar 2024,
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,247,212 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Laurion Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and HRT FINANCIAL LP.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.